Patent · US Active

Polypeptides and uses thereof for treatment of autoimmune disorders and infection

US9428574B2 · kind B2 · utility

0Cited by
152References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 1, 2012
Grant dateAug 30, 2016
Priority date
Expiry dateOct 3, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to C1ORF32 protein and its variants and fragments and fusion proteins thereof, pharmaceutical composition comprising same and methods of use thereof for treatment of immune related disorders and infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.